超性心肌病的实验模型:一个系统的审查
Floor W van den Dolder1, Rafeeh Dinani1, Vincent A J Warnaar1
1Department of Physiology, Amsterdam University Medical Center (UMC), Location VUmc, Amsterdam, the Netherlands; Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, the Netherlands.
JACC. Basic to translational science
|April 30, 2025
概括
研究人员审查了多变性心肌病 (HCM) 模型,发现动物模型和人类诱导的多能干细胞衍生心肌细胞 (hiPSC-CMs) 显示出有限的疾病标志物. 为了最佳的模型选择,需要更好地报告研究细节.
科学领域:
- 心血管研究研究心血管研究
- 遗传学 遗传学 是一个
- 再生医学是一种再生医学.
背景情况:
- 增高性心肌病变 (HCM) 是一种遗传性心肌疾病.
- 开发准确的模型对于理解HCM病原体和测试疗法至关重要.
- 现有的模型在回顾关键HCM特征的能力上有所不同.
研究的目的:
- 系统地审查基因变异诱导的多变性心肌病的实验模型.
- 为了确定在不同的模型系统中存在哪些HCM的主要标志.
- 引导研究人员选择适合他们特定研究问题的模型.
主要方法:
- 对603篇研究HCM模型的论文进行系统文献综述.
- 模型的分类为动物模型和人类诱导的多能干细胞衍生心肌细胞 (hiPSC-CMs).
- 评估每个模型中存在的标志性疾病标志物.
主要成果:
- 自2010年以来,人们开始转向使用hiPSC-CMs.
- 只有36个小鼠模型表现出6个HCM疾病标志物中的4个.
- 只有17个hiPSC-CM模型显示了4个HCM细胞特征中的3个.
- 报告中对样本大小,性别,年龄和疾病特征的报告不完全.
结论:
- 目前的实验模型,包括动物和hiPSC-CMs,不完全重复过度缩性心肌病.
- 需要对实验细节进行更全面的报告,以改善模型选择和可重复性.
- 需要进一步开发体外和体内模型,以更好地代表HCM复杂性.
相关概念视频
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


